background and purpose: the clinical outcome of intrauterine insemination (iui) treatment cycles employing a gonadotrophin-releasing hormone agonist [superfact)] or human chorionic gonadotrophin (hcg) for ovulation induction was compared. materials and methods: a group of 100 patients presenting with amenorrhoea, oligomenorrhoea or unexplained infertility were all treated with clomiphene 100 mg...

background: general concern is that the pregnancy rate is higher with gnrh-agonist as a protocol of pituitary suppression. gnrh-antagonist protocol provides a shorter period of administration and an easy flexible protocol. objective: in this study, the outcomes of gnrh agonist and antagonist in icsi cycles are compared in normo responder patients. materials and methods: in this randomized clini...

background: polycystic ovarian syndrome (pcos) patients are prone to premature lh surge and ovarian hyperstimulation syndrome (ohss). long gnrh analogue protocol and gnrh antagonist protocol are two methods utilized for induction ovulation in patients undergoing ivf/icsi. objective: the aim of this study was to compare the effects of gnrh agonists and antagonists in pcos patients. materials and...

abstract the gnrh analogue (agonist and antagonist gnrh) changed ovarian stimulation. on the one hand, it improved chances of pregnancy to obtain more oocytes and better embryos. this leads to an ovarian hyper-response, which can be complicated by the ovarian hyperstimulation syndrome (ohss). on the other hand, the gnrh analogue can prevent the incidence of ohss: gnrh antagonist protocols, gnrh...

background: to compare a flexible, multi-dose gnrh antagonist protocol with a long gnrh .agonist protocol in poor respo materials and methods: a randomized clinical trial of 70 poor responder patients (35 patients in gnrh antagonist protocol and 35 patients in long gnrh agonist protocol) was performed at royan institute, tehran, iran. both groups were given a fixed dose of human menopausal gona...

background: prolonged gnrh-a administration in ivf cycles may have some advantages related to the treatment outcomes. objective: in this study, we aimed to analyse the effect of prolonged gonadotropin releasing hormone agonist (gnrh-a) administration on controlled ovarian hyperstimulation outcomes of in vitro fertilization (ivf) patients. materials and methods: in this retrospective study, 55 p...

Background To compare a flexible, multi-dose GnRH antagonist protocol with a long GnRH .agonist protocol in poor respo MaterialsAndMethods A randomized clinical trial of 70 poor responder patients (35 patients in GnRH antagonist protocol and 35 patients in long GnRH agonist protocol) was performed at Royan Institute, Tehran, Iran. Both groups were given a fixed dose of human menopausal gonadotr...

objective: coasting can reduce the ovarian hyperstimulation syndrome (ohss) risk in ovulation induction cycles before intracytoplasmic sperm injection (icsi). this study aimed to investigate the effect of gonadotropin-releasing hormone (gnrh) agonist and gnrh antagonist protocols to controlled ovarian hyperstimulation (coh) cycles with coasting on the parameters of icsi cycles and the outcome. ...

Objective Coasting can reduce the ovarian hyperstimulation syndrome (OHSS) risk in ovulation induction cycles before intracytoplasmic sperm injection (ICSI). This study aimed to investigate the effect of gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist protocols to controlled ovarian hyperstimulation (COH) cycles with coasting on the parameters of ICSI cycles and the outcome. M...